Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Nov 9:5:164.
doi: 10.3389/fcvm.2018.00164. eCollection 2018.

The Conundrum of Tricuspid Regurgitation Grading

Affiliations
Review

The Conundrum of Tricuspid Regurgitation Grading

Yun Yun Go et al. Front Cardiovasc Med. .

Abstract

Findings from early percutaneous tricuspid intervention trials have shown that the severity of tricuspid regurgitation (TR) far exceeded the current definition of severe TR. Also, the improvement in the amount of TR following tricuspid intervention is not accounted for by the current definition of TR as different degrees of severity at the severe end was grouped under the same umbrella term of "severe." There has been a recent call to expand the TR grading system, encompassing two more grades, namely "massive" and "torrential" TR, in the order of increasing severity. This seems appropriate as the patients enrolled in tricuspid intervention trials were found to have TR severity up to 2 grades above the current severe thresholds of effective regurgitant orifice area (EROA) 40 mm2, regurgitant volume (R Vol) 45 ml and vena contracta (VC) width 7 mm. The proposed grade of "massive" is defined by EROA 60-79 mm2, R Vol 60-74 ml and VC 14-20 mm, while "torrential" is defined by EROA ≥80 mm2, R Vol ≥75 ml, and VC ≥21 mm. The grading of TR requires a comprehensive, multi-parametric approach. In particular, quantitative assessment of TR should be performed in patients who require serial monitoring and quantification of treatment effect.

Keywords: echocardiography; massive tricuspid regurgitation; percutaneous intervention; torrential tricuspid regurgitation; tricuspid regurgitation grading.

PubMed Disclaimer

References

    1. Lancellotti P, Fattouch K, Dulgheru R. Targeting the tricuspid valve: a new therapeutic challenge. Arch Cardiovasc Dis. (2016) 109:1–3. 10.1016/j.acvd.2015.11.001 - DOI - PubMed
    1. Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol. (2004) 43:405–9. 10.1016/j.jacc.2003.09.036 - DOI - PubMed
    1. Topilsky Y, Nkomo VT, Vatury O, Michelena HI, Letourneau T, Suri RM, et al. . Clinical outcome of isolated tricuspid regurgitation. JACC Cardiovasc Imaging (2014) 7:1185–94. 10.1016/j.jcmg.2014.07.018 - DOI - PubMed
    1. Stuge O, Liddicoat J. Emerging opportunities for cardiac surgeons within. J Thorac Cardiovasc Surg. (2006) 132:1258–61. 10.1016/j.jtcvs.2006.08.049 - DOI - PubMed
    1. Zack CJ, Fender EA, Chandrashekar P, Reddy YNV, Bennett CE, Stulak JM, et al. . National trends and outcomes in isolated tricuspid valve surgery. J Am Coll Cardiol. (2017) 70:2953–60. 10.1016/j.jacc.2017.10.039 - DOI - PubMed